Predicting fracture risk for treated, untreated patients

A new study summarizes the clinical performance of serum procollagen type I N propeptide and serum C-terminal cross-linking telopeptide of type I collagen in fracture risk prediction in untreated individuals in prospective cohort studies.

http://ift.tt/NN3VP5